Learn More
BACKGROUND HER2-positive breast cancer consists of four intrinsic molecular subtypes-luminal A, luminal B, HER2-enriched, and basal-like-and a normal-like subtype, with the HER2-enriched subtype(More)
756 Background: To evaluate the efficacy and toxicity profile of VNR and LTZ in aged women with MBC. METHODS Between April 2001 and August 2003, fifty-three women with measurable MBC, no prior(More)